Sort   by:  
 Page size 
UnknownPhase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
Not available
S-EPMC3577951 | biostudies-literature
ModelsTroein2011_ClockCircuit_OstreococcusTauri
This model is from the article: Multiple light inputs to a simple clock circuit allow complex biological rhythms Troein C, Corellou F, Dixon LE, van Ooijen G, O'Neill JS, Bouget FY, Millar AJ. Plant J.2011 Apr;66(2):375-85. 21219507, Abstract: ...
2024-09-02 | BIOMD0000000350 | BioModels
UnknownPharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C3] in Mice and Primates.
Not available
S-EPMC6128740 | biostudies-literature
UnknownLong-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Not available
S-EPMC9857594 | biostudies-literature
UnknownPhase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
Not available
S-EPMC3157965 | biostudies-literature
UnknownDelirium in Survivors of Cardiac Arrest Treated With Mild Therapeutic Hypothermia.
Not available
S-EPMC5240926 | biostudies-literature
UnknownFgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia.
Not available
S-EPMC5164852 | biostudies-literature
UnknownRandomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
Not available
S-EPMC4890680 | biostudies-literature
UnknownImmunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study.
Not available
S-EPMC9870748 | biostudies-literature
UnknownReducing Hospital Readmissions Through Preferred Networks Of Skilled Nursing Facilities.
Not available
S-EPMC5664928 | biostudies-literature
Sort   by:  
 Page size